CSL don't have the facilities to make those 2 vaccines. Astrazeneca they can do with existing equipment, hence they've been making it for months.
Astrazeneca has been 90%+ on efficacy with a half dose first so not sure what all the fuss is about.
Either way CSL's success does not revolve around a covid vaccine. Total market overreaction. Once a few other sectors quieten down, it'll bounce. When CSL corrects, it does it quickly. Excellent buying at this level in my opinion..
CSL don't have the facilities to make those 2 vaccines....
-
- There are more pages in this discussion • 425 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$295.16 |
Change
0.280(0.09%) |
Mkt cap ! $142.6B | |||
| Open | High | Low | Value | Volume |
| $291.86 | $295.16 | $289.25 | $165.9M | 565.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500 | $295.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $295.16 | 3815 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |